335 related articles for article (PubMed ID: 23924316)
1. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.
Lin LT; Chen TY; Lin SC; Chung CY; Lin TC; Wang GH; Anderson R; Lin CC; Richardson CD
BMC Microbiol; 2013 Aug; 13():187. PubMed ID: 23924316
[TBL] [Abstract][Full Text] [Related]
2. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread.
Lin LT; Chen TY; Chung CY; Noyce RS; Grindley TB; McCormick C; Lin TC; Wang GH; Lin CC; Richardson CD
J Virol; 2011 May; 85(9):4386-98. PubMed ID: 21307190
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cell surface glycosaminoglycans in chebulagic acid's and punicalagin's antiviral activities against Coxsackievirus A16 infection.
Liu CH; Kuo YT; Lin CJ; Lin LT
Phytomedicine; 2023 Nov; 120():155047. PubMed ID: 37690230
[TBL] [Abstract][Full Text] [Related]
4. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL
Du R; Cooper L; Chen Z; Lee H; Rong L; Cui Q
Antiviral Res; 2021 Jun; 190():105075. PubMed ID: 33872675
[TBL] [Abstract][Full Text] [Related]
5. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.
Kesharwani A; Polachira SK; Nair R; Agarwal A; Mishra NN; Gupta SK
BMC Complement Altern Med; 2017 Feb; 17(1):110. PubMed ID: 28196487
[TBL] [Abstract][Full Text] [Related]
6. Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding.
Lin CJ; Liu CH; Wang JY; Lin CC; Li YF; Richardson CD; Lin LT
Emerg Microbes Infect; 2018 Sep; 7(1):162. PubMed ID: 30254193
[TBL] [Abstract][Full Text] [Related]
7. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
8. Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16.
Wang JY; Lin CJ; Liu CH; Lin LT
J Vis Exp; 2019 Jul; (149):. PubMed ID: 31355786
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.
Haid S; Grethe C; Bankwitz D; Grunwald T; Pietschmann T
J Virol; 2015 Dec; 90(6):3065-73. PubMed ID: 26719246
[TBL] [Abstract][Full Text] [Related]
10. Studies on the antiviral activity of chebulinic acid against dengue and chikungunya viruses and in silico investigation of its mechanism of inhibition.
Thomas N; Patil P; Sharma A; Kumar S; Singh VK; Alagarasu K; Parashar D; Tapryal S
Sci Rep; 2022 Jun; 12(1):10397. PubMed ID: 35729191
[TBL] [Abstract][Full Text] [Related]
11. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
12. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.
Vanheule V; Vervaeke P; Mortier A; Noppen S; Gouwy M; Snoeck R; Andrei G; Van Damme J; Liekens S; Proost P
Biochem Pharmacol; 2016 Jan; 100():73-85. PubMed ID: 26551597
[TBL] [Abstract][Full Text] [Related]
13. The Geraniin-Rich Extract from Reunion Island Endemic Medicinal Plant
Haddad JG; Grauzdytė D; Koishi AC; Viranaicken W; Venskutonis PR; Nunes Duarte Dos Santos C; Desprès P; Diotel N; El Kalamouni C
Molecules; 2020 May; 25(10):. PubMed ID: 32429073
[TBL] [Abstract][Full Text] [Related]
14. Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry.
Shoup M; Ourahmane A; Ginsburg EP; Farrell NP; McVoy MA
Antiviral Res; 2020 Dec; 184():104957. PubMed ID: 33132195
[TBL] [Abstract][Full Text] [Related]
15. Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA.
Liu C; Cai D; Zhang L; Tang W; Yan R; Guo H; Chen X
Antiviral Res; 2016 Oct; 134():97-107. PubMed ID: 27591143
[TBL] [Abstract][Full Text] [Related]
16. Virus entry: old viruses, new receptors.
Backovic M; Rey FA
Curr Opin Virol; 2012 Feb; 2(1):4-13. PubMed ID: 22440960
[TBL] [Abstract][Full Text] [Related]
17. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.
Mazzon M; Ortega-Prieto AM; Imrie D; Luft C; Hess L; Czieso S; Grove J; Skelton JK; Farleigh L; Bugert JJ; Wright E; Temperton N; Angell R; Oxenford S; Jacobs M; Ketteler R; Dorner M; Marsh M
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791609
[TBL] [Abstract][Full Text] [Related]
18. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
[TBL] [Abstract][Full Text] [Related]
19. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
Krepstakies M; Lucifora J; Nagel CH; Zeisel MB; Holstermann B; Hohenberg H; Kowalski I; Gutsmann T; Baumert TF; Brandenburg K; Hauber J; Protzer U
J Infect Dis; 2012 Jun; 205(11):1654-64. PubMed ID: 22457281
[TBL] [Abstract][Full Text] [Related]
20. Structural Insight into Non-Enveloped Virus Binding to Glycosaminoglycan Receptors: A Review.
Sorin MN; Kuhn J; Stasiak AC; Stehle T
Viruses; 2021 Apr; 13(5):. PubMed ID: 33946963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
